Biomarkers of CIDP in patients with diabetes or CMT1

Journal of the Peripheral Nervous System

Volumn 16, Issue SUPPL. 1, 2011, Pages 14-17

  Latov, Norman ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

biomarker; CIDP; CMT1; diabetes; diagnosis

Indexed keywords

CORTICOSTEROID DERIVATIVE; IMMUNOGLOBULIN;

ARTICLE; CELL FUNCTION; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; HEREDITARY MOTOR SENSORY NEUROPATHY; MACROPHAGE; MORBIDITY; NERVE BIOPSY; PRIORITY JOURNAL; SKIN BIOPSY; SURAL NERVE;

BIOLOGICAL MARKERS; CHARCOT-MARIE-TOOTH DISEASE; DIABETIC NEUROPATHIES; DIAGNOSIS, DIFFERENTIAL; HUMANS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 79959585578     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2011.00299.x     Document Type: Article

References (29)

1. Chio A, Cocito D, Bottacchi E, Buffa C, Leone M, Plano F, Mutani R, Calvo A, Piemonte and Valle D'Aosta Registry for CIDP (2007). Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy. J Neurol Neurosurg Phsychiatry 78: 1349-1353. (Pubitemid 350221415)
2. Chio A, Plano F, Calvo A, Leone M, Mutani R, Cocito D, Piemonte and Valle D'Aosta Registry for CIDP (2009). Comorbidity between CIDP and diabetes mellitus: only a matter of chance? Eur J Neurol 16: 752-754.
3. Dace DS, Khan AA, Stark JL, Kelly J, Cross AH, Apte RS, (2009). Interleukin-10 overexpression promotes Fas-ligand dependent chronic macrophage-mediated demyelinating polyneuropathy. PLoS one 4: e7121.
4. De Sousa EA, Chin RL, Sander HW, Latov N, Brannagan TH, (2009). Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity. Clin Neuromusc Dis 10: 163-169.
5. Desurkar A, Lin JP, Mills K, Al-Sarraj S, Jan W, Jungbluth H, Wraige E, (2009). Charcot-Marie-Tooth (CMT) disease 1A with superimposed inflammatory polyneuropathy in children. Neuropediatrics 40: 85-88.
6. Donaghy M, Sisodiya SM, Kennett R, McDonald B, Haites N, Bell C, (2000). Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation. J Neurol Neurosurg Psychiat 69: 799-805.
7. Dyck PJ, Swanson CJ, Low PA, Bartleson JD, Lambert EH, (1982). Prednisone-reponsive hereditary motor and sensory neuropathy. Mayo Clin Proc 57: 239-256.
8. Ginsberg L, Malik O, Kenton AR, Sharp D, Muddle JR, Davis MB, Winer JB, Orrell RW, King RH, (2004). Coexistent hereditary and inflammatory neuropathy. Brain 127: 193-202. (Pubitemid 38055358)
9. Gorson KC, Ropper AH, Adelman LS, Weinberg DH, (2000). Infuence of diabetes mellitus on chronic inflammatory demyelinating polyeneuropathy. Muscle Nerve 23: 37-43. (Pubitemid 30013861)
10. Jacob S, Rajabally YA, (2009). Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathy. Curr Neuropharmacol 7: 337-342.
11. Jann S, Bramerio MA, Beretta S, Koch S, Defanti CA, Toyka KV, Sommer C, (2003). Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP. Neurology 61: 1607-1610. (Pubitemid 37505589)
12. Kalita J, Misra UK, Yadav HK, (2007). A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus. Eur J Neurol 14: 638-643. (Pubitemid 46849062)
13. Kiefer R, Dangond F, Mueller M, Toyka KV, Hafler DA, Hartung HP, (2000). Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies. J Neurol Neurosurg Phsychiatry 69: 362-368. (Pubitemid 30636240)
14. Laughlin RS, Dyck PJ, Melton LJ 3rd, Leisbon C, Ranson J, Dyck PJ, (2009). Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology 73: 39-45.
15. Lee G, Xiang Z, Brannagan TH, Chin RL, Latov N, (2010a). Differential gene expression in chronic inflammatory demyelinating polyneurpathy (CIDP) skin biopsies. J Neurol Sci 290: 115-122.
16. Lee G, Igarashi Y, Latov N, (2010b). Therapy of experimental inflammatory demyelinating neuropathy with anti-MSR1 IgG Fab. Ann Neurol 68: S56.
17. Lozeron P, Nahum L, Lacroix C, Ropert A, Guglielmi J-M, Said G, (2002). Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol 249: 569-575. (Pubitemid 34507831)
18. Marques W, Funayama CAR, Secchin JB, Lourenco CM, Gouvea SP, Marques VD, Bastos PG, Barreira AA, (2010). Coexistence of two chronic neuropathies in a young child; Charctot-Marie-Tooth disease type 1A and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 42: 598-600.
19. Martyn CN, Hughes RAC, (1997). Epidemiology of peripheral neuropathy. J Neurol Neurosurg Phsychiatry 62: 310-318. (Pubitemid 27199100)
20. Nodera H, Chin R, Langsdorf J, Carey B, Latov N, (2010). Electrodiagnostic features of CIDP in diabetes mellitus. Neurology 74: A522.
21. Pareyson D, (2004). Differential diagnosis of Charcot-Marie-Tooth disease and related neuropathies. Neurol Sci 25: 72-82. (Pubitemid 38923546)
22. Scelsa SN, (2010). Familial, demyelinating sensory and motor polyneuropathy with conduction block. Muscle Nerve 41: 558-562.
23. Sharma KR, Cross J, Farranay O, Ayyar DR, Shebert RT, Bradly WG, (2002). Demyelinating neuropathy in diabetes mellitus. Arch Neurol 59: 758-765. (Pubitemid 34517757)
24. Sommer C, Koch S, Lammens M, Gabreels-Festen A, Stoll G, Toyka KV, (2005). Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Neurology 65: 1924-1929. (Pubitemid 43970112)
25. Stewart JD, McKelvey R, Durcan L, Carpenter S, Karpati G, (1996). Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabtetics. J Neurol Sci 142: 59-64. (Pubitemid 26340410)
26. Uncini A, De Angelis MV, Di Muzio A, Callegarini C, Ciucci G, Antonini G, Lugaresi A, Gambi D, (1999). Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important for differential diagnosis with diabetic polyneuropathy. Clin Neurophysiol 110: 705-711. (Pubitemid 29236400)
27. Vital C, Vital A, Lagueny A, Fontan D, Barat M, Gbikpi-Benissan G, Orgogozo JM, Henry P, Brechenmacher C, Bredin A, Desbordes P, RibiÃre-Bachelier C, Latinville D, Julien J, Pétry KG, (2000). Chronic inflammatory demyelinating polyneurpathy: immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases. Ultrastruct Pathol 24: 363-369. (Pubitemid 32060307)
28. Watanabe M, Yamamoto N, Ohkoshi N, Nagata H, Kohno Y, Hayashi A, Tamaoka A, Shoji S, (2002). Corticosteroid responsive asymmetric neuropathy with a myelin protein zero gene mutation. Neurology 59: 767-769.
29. Wilson JR, Park Y, Fisher MA, (2000). Electrodiagnostic criteria in CIDP: comparison with diabetic neuropathy. Electromyogr Clin Neurophysiol 40: 181-185. (Pubitemid 30218894)